AsianScientist (Nov. 14, 2011) – Invida Holdings Private Limited, a specialty biopharmaceutical company focused on the commercialization of healthcare brands throughout Asia Pacific, today announced the acquisition of a brand portfolio from India-based Shalaks Pharmaceuticals Pvt Ltd (Shalaks).
Shalaks Pharmaceuticals, founded in 1979, is based in New Delhi with India-wide sales network. The company has a focused portfolio in dermatology and primary care products.
Invida will focus its sales and marketing efforts on high volume dermatology brands in key growth segments, including topical anti-acne, anti-fungal, sun screens, anti-scar, anti-pigmentation, and moisturizers.
The primary care portfolio, comprising seven brands, will establish Invida in key market segments that are poised for growth.
No financial terms of the acquisition were disclosed. Upon acquisition of the product portfolio from Shalaks, Invida will market the products under the Invida brand.
“This is an important strategic move for Invida, expanding our presence in the rapidly growing Indian pharmaceutical market,” said Invida CEO John Graham.
“This product portfolio, combined with our recent addition of products from Sinclair Pharmaceuticals, allows us to target the Indian market with both high-end differentiated and main stream dermatology products. The acquisition of Shalaks’ products positions Invida among the top dermatology companies in India – with the significant potential to increase this position in the coming years,” Graham said.
According to Invida’s press report, the Indian pharmaceutical market is currently valued at US$10 billion and one of the fastest growing markets in the world, forecasted to grow in double-digits in medium term.
Valued at US$513 million, the Indian dermatology market grew by 21 percent in 2010 and represents 25 percent of the Asia-Pacific dermatology market.
MAPE Advisory Group was Invida’s advisor on this transaction.
——
Source: Invida Group Pte Ltd.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
